Cargando…

Double‐blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study

SETTING: Bariatric surgery is indicated for patients diagnosed with obesity and type 2 diabetes. Many patients achieve type 2 diabetes remission soon after bariatric surgery. Even though most maintain good glycemic control, remission is not maintained in all patients, and as a result, some patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashyap, Sangeeta R., Kheniser, Karim, Aminian, Ali, Schauer, Philip, Le Roux, Carel, Burguera, Bartolome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278903/ https://www.ncbi.nlm.nih.gov/pubmed/32523714 http://dx.doi.org/10.1002/osp4.409

Ejemplares similares

Incidence and Clinical Features of Diabetic Ketoacidosis After Bariatric and Metabolic Surgery
por: Aminian, Ali, et al.
Publicado: (2016)

Bariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes
por: Brethauer, Stacy A., et al.
Publicado: (2014)

Association of prior metabolic and bariatric surgery with severity of coronavirus disease 2019 (COVID-19) in patients with obesity
por: Aminian, Ali, et al.
Publicado: (2021)

Changes in Whole Blood Gene Expression in Obese Subjects with Type 2 Diabetes Following Bariatric Surgery: a Pilot Study
por: Berisha, Stela Z., et al.
Publicado: (2011)

Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA)
por: Aminian, Ali, et al.
Publicado: (2020)

Response to Comments on Brethauer et al. Bariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes. Diabetes Care 2014;37:e51–e52
por: Kirwan, John P., et al.
Publicado: (2014)

The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes
por: Kashyap, Sangeeta, et al.
Publicado: (2016)

Erratum to: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes
por: Kashyap, Sangeeta, et al.
Publicado: (2016)

The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer
por: Ross, Robert C., et al.
Publicado: (2022)

Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes
por: Lorkowski, Shuhui Wang, et al.
Publicado: (2020)

Comment on: Impact of serum uric acid on renal function after bariatric surgery: a retrospective study
por: Martin, William P., et al.
Publicado: (2020)

Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study
por: Sha, S., et al.
Publicado: (2015)

Effect of Bariatric Surgery Versus Intensive Medical Management on Diabetic Ophthalmic Outcomes
por: Singh, Rishi P., et al.
Publicado: (2015)

Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
por: Papamargaritis, Dimitris, et al.
Publicado: (2021)

Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
por: Kheniser, Karim G., et al.
Publicado: (2020)

Bariatric Surgery: It’s Not Just Incretins!
por: Ferraz-Bannitz, Rafael, et al.
Publicado: (2021)

Outcomes of Bariatric Surgery in Morbidly Obese Patients with Multiple Sclerosis
por: Bencsath, Kalman, et al.
Publicado: (2017)

The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?
por: Gorman, Dora M., et al.
Publicado: (2016)

The role of bariatric surgery to treat diabetes: current challenges and perspectives
por: Koliaki, Chrysi, et al.
Publicado: (2017)

SAT-101 The Combination of Anti-Obesity Medications and Bariatric Surgery Can Be Effective in Resetting the Cerebral Adipostat in Individuals with Autism Suffering from Severe Obesity
por: Bhardwaj, Nakul, et al.
Publicado: (2019)

Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials
por: Gloy, Viktoria L, et al.
Publicado: (2013)

Aspartame Sensitivity? A Double Blind Randomised Crossover Study
por: Sathyapalan, Thozhukat, et al.
Publicado: (2015)

The metabolic benefits of different bariatric operations: what procedure to choose?
por: Sudlow, Alexis, et al.
Publicado: (2020)

Outcomes of a Third Bariatric Procedure for Inadequate Weight Loss
por: Daigle, Christopher R., et al.
Publicado: (2014)

Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study†
por: Inagaki, N, et al.
Publicado: (2013)

Short‐term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo‐controlled, double‐blind, study
por: Lindåse, Sanna, et al.
Publicado: (2023)

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program
por: Weir, Matthew R, et al.
Publicado: (2020)

How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?
por: Bächler, Thomas, et al.
Publicado: (2016)

Medication following bariatric surgery for type 2 diabetes mellitus (BY-PLUS) study: rationale and design of a randomised controlled study
por: Sudlow, Alexis, et al.
Publicado: (2022)

A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function
por: Kheniser, K. G., et al.
Publicado: (2019)

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Nonopioid versus opioid based general anesthesia technique for bariatric surgery: A randomized double-blind study
por: Mansour, Mohamed Ahmed, et al.
Publicado: (2013)

Pregabalin to improve postoperative recovery in bariatric surgery: a parallel, randomized, double-blinded, placebo-controlled study
por: Martins, Marcelo J, et al.
Publicado: (2018)

Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery
por: Khanna, Vishesh, et al.
Publicado: (2015)

An Exploration of the Patient Lived Experience of Remission and Relapse of Type 2 Diabetes Following Bariatric Surgery
por: Sudlow, Alexis C., et al.
Publicado: (2021)

Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment
por: Kashyap, Sangeeta R., et al.
Publicado: (2013)

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
por: Mahaffey, Kenneth W., et al.
Publicado: (2018)

Male Obesity Associated Gonadal Dysfunction and the Role of Bariatric Surgery
por: Sultan, Sana, et al.
Publicado: (2020)

Canagliflozin – Beginning of the journey
por: Pandey, Sunil Kumar, et al.
Publicado: (2014)

Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
por: McCrimmon, Rory J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2i55pf7eluu9r05mtdhmgn265t